EVELO BIOSCIENCES INC - COM (EVLO)

CUSIP: 299734103

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
28,616,174
Share change
-350,545
Total reported value
$107,547,809
Price per share
$3.75
Number of holders
40
Value change
-$1,517,042
Number of buys
14
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 299734103?
CUSIP 299734103 identifies EVLO - EVELO BIOSCIENCES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVELO BIOSCIENCES INC - COM (EVLO) as of Q1 2020

As of 31 Mar 2020, EVELO BIOSCIENCES INC - COM (EVLO) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,616,174 shares. The largest 10 holders included Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, CREDIT SUISSE AG/, Alphabet Inc., BlackRock Inc., Mayo Clinic, VANGUARD GROUP INC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.